Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications

Area of Science:

• Microbiology
• Immunology
• Metabolic Health

Background:

• The gut microbiota plays a vital role in host homeostasis and immune system maturation.
• Gut dysbiosis and impaired intestinal barrier function increase immune cell exposure to microbial components.
• Microbial molecules like PAMPs and metabolites can trigger inflammation, contributing to metabolic diseases.

Purpose of the Study:

• To review the influence of gut microbiota on chronic inflammation.
• To explore the benefits of microbiota modification for reducing inflammation and improving metabolic profiles.
• To discuss personalized approaches to microbiota modulation based on dysbiosis type.

Main Methods:

• Systematization of existing scientific literature on gut microbiota and inflammation.
• Analysis of studies on dietary interventions, prebiotics, and probiotics for microbiota modification.
• Review of research on the impact of microbiota modulation on inflammatory and metabolic markers.

Main Results:

• Microbiota modification, through diet, prebiotics, and probiotics, shows potential in reducing inflammation and improving metabolic health.
• Personalized strategies are necessary as there is no universal definition of a 'healthy' microbiota.
• The effectiveness of interventions depends on the specific type of gut dysbiosis.

Conclusions:

• Gut microbiota significantly impacts chronic inflammation and metabolic diseases.
• Targeted microbiota modulation offers therapeutic potential but requires individualized approaches.
• Further research is essential to fully understand the complex interactions between microbiota, inflammation, and host health.